Bethan Hughes investigates how the Chinese government's efforts to boost innovation have resulted in drug discovery research collaborations between Chinese academic institutions and multinational pharmaceutical companies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation
Globalization and Health Open Access 19 November 2014
-
Public funding and private investment for R&D: a survey in China’s pharmaceutical industry
Health Research Policy and Systems Open Access 13 June 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
China spurs pharma innovation. Nat Rev Drug Discov 9, 581–582 (2010). https://doi.org/10.1038/nrd3238
Issue Date:
DOI: https://doi.org/10.1038/nrd3238
This article is cited by
-
Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation
Globalization and Health (2014)
-
Public funding and private investment for R&D: a survey in China’s pharmaceutical industry
Health Research Policy and Systems (2014)
-
Bibliometrics evaluation of research performance in pharmacology/pharmacy: China relative to ten representative countries
Scientometrics (2013)